Diagnosis and Management of Autoimmune Hemolytic Anemias
Autoimmune hemolytic anemia (AIHA) is usually categorized, as other immune-mediated cytopenias, in so-called benign hematology, and it is consequently managed in various settings, namely, internal medicine, transfusion centers, hematology and, more rarely, onco-hematology departments [...]
Main Authors: | Wilma Barcellini, Bruno Fattizzo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/20/6029 |
Similar Items
-
Infectious Complications in Autoimmune Hemolytic Anemia
by: Juri Alessandro Giannotta, et al.
Published: (2021-01-01) -
Cytokine polymorphisms in patients with autoimmune hemolytic anemia
by: Anna Zaninoni, et al.
Published: (2023-11-01) -
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
by: Sigbjørn Berentsen, et al.
Published: (2023-04-01) -
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
by: Wilma Barcellini, et al.
Published: (2020-11-01) -
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
by: Bruno Fattizzo, et al.
Published: (2020-11-01)